Benzinga | Aug 13, 2021 05:18AM EDT

Baird Initiates Coverage On Instil Bio with Outperform Rating, Announces Price Target of $34

Baird analyst Jack Allen initiates coverage on Instil Bio (NASDAQ:TIL) with a Outperform rating and announces Price Target of $34.